Abstract | OBJECTIVES: METHODS: RESULTS: Thirty-nine of 49 patients (79.6%) were converted with quinidine and only one of the remaining 10 was converted with electrical cardioversion. Quinidine had no significant effect on blood pressure or unexpected changes on the QRS duration and the QT interval. Four patients developed gastrointestinal symptoms (8.1%). CONCLUSIONS:
|
Authors | C Kirpizidis, A Stavrati, P Geleris, H Boudoulas |
Journal | Journal of cardiology
(J Cardiol)
Vol. 38
Issue 6
Pg. 351-4
(Dec 2001)
ISSN: 0914-5087 [Print] Netherlands |
PMID | 11806093
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Administration, Oral
- Aged
- Atrial Fibrillation
(drug therapy)
- Electric Countershock
- Female
- Humans
- Male
- Middle Aged
- Prospective Studies
- Quinidine
(administration & dosage, analogs & derivatives)
- Treatment Outcome
|